Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: In vitro simulation of the liver first-pass effect with biotransformation-competent HepG2 cells to study effects of MG-132 on liver and cancer cells, Clinical Hemorheology and Microcirculation, August 2023, IOS Press,
DOI: 10.3233/ch-238108.
You can read the full text:

Read

Contributors

The following have contributed to this page